FTC 200mg+TDF 300mg tabs/PAC-30 gb

General Description
Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg tablets, pack of 30

Technical Specifications
Each film coated tablet contains Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil as fixed dose combination (FDC).

Therapeutic class
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Standard shelf life
2 years (24 months)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Indications
Management of HIV-1 infection in adults in combination with at least one other antiretroviral drug. By mouth (oral), PO

Storage
Do not store above 30ºC (86ºF).
Store in a tightly closed container.
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack
Can be taken with or without food

Regulatory Status
For latest updates check the list of Prequalified Medicines on the WHO website Prequalification Programme. apps.who.int/prequal/

For latest updates check the list of USFDA approved and tentatively approved items on the USFDA website. www.fda.gov/default.htm, www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/